Clinical Trial

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A multicenter, randomized, double-blind, phase Ⅳ study to evaluate the long-term efficacy and safety of Pitavastatin/Ezetimibe and Pitavastatin in patients with hypercholesterolemia with elevated triglycerides
Trial Details
NCT Number NCT07442630
Lead Sponsor JW Pharmaceutical
Conditions Hypercholesterolemia
Enrollment 88 participants
Start Date 2023-08-21
Primary Completion 2026-01-22 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-02